2,3,4,6-Tetra-O-methyl-alpha-D-glucopyranose

Details

Top
Internal ID af5f6c42-dbb2-454a-9b63-c832bd00c3aa
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Monosaccharides > Hexoses
IUPAC Name (2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-ol
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C10H20O6/c1-12-5-6-7(13-2)8(14-3)9(15-4)10(11)16-6/h6-11H,5H2,1-4H3/t6-,7-,8+,9-,10+/m1/s1
InChI Key AQWPITGEZPPXTJ-SPFKKGSWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H20O6
Molecular Weight 236.26 g/mol
Exact Mass 236.12598835 g/mol
Topological Polar Surface Area (TPSA) 66.40 Ų
XlogP -1.00
Atomic LogP (AlogP) -0.60
H-Bond Acceptor 6
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
6163-35-5
RefChem:935253
GlyTouCan:G95689BH
G95689BH
2,3,4,6-tetra-O-methyl-alpha-D-glucopyranose
228-192-3
2,3,4,6-Tetra-O-methylhexopyranose
EINECS 228-192-3
SCHEMBL6815629
DTXSID60977224
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 2,3,4,6-Tetra-O-methyl-alpha-D-glucopyranose

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.4820 48.20%
Caco-2 + 0.5220 52.20%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.6842 68.42%
OATP2B1 inhibitior - 0.8557 85.57%
OATP1B1 inhibitior + 0.9010 90.10%
OATP1B3 inhibitior + 0.9286 92.86%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.9331 93.31%
P-glycoprotein inhibitior - 0.9356 93.56%
P-glycoprotein substrate - 0.9641 96.41%
CYP3A4 substrate - 0.5571 55.71%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8275 82.75%
CYP3A4 inhibition - 0.8797 87.97%
CYP2C9 inhibition - 0.9019 90.19%
CYP2C19 inhibition - 0.8333 83.33%
CYP2D6 inhibition - 0.9172 91.72%
CYP1A2 inhibition - 0.9193 91.93%
CYP2C8 inhibition - 0.9177 91.77%
CYP inhibitory promiscuity - 0.9189 91.89%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8800 88.00%
Carcinogenicity (trinary) Non-required 0.6253 62.53%
Eye corrosion - 0.9607 96.07%
Eye irritation - 0.7840 78.40%
Skin irritation - 0.8601 86.01%
Skin corrosion - 0.9750 97.50%
Ames mutagenesis - 0.7500 75.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5371 53.71%
Micronuclear - 0.7426 74.26%
Hepatotoxicity - 0.5574 55.74%
skin sensitisation - 0.8328 83.28%
Respiratory toxicity - 0.8444 84.44%
Reproductive toxicity - 0.7222 72.22%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity - 0.5841 58.41%
Acute Oral Toxicity (c) III 0.7293 72.93%
Estrogen receptor binding - 0.8314 83.14%
Androgen receptor binding - 0.8115 81.15%
Thyroid receptor binding + 0.5843 58.43%
Glucocorticoid receptor binding - 0.7187 71.87%
Aromatase binding - 0.7726 77.26%
PPAR gamma - 0.7086 70.86%
Honey bee toxicity - 0.8832 88.32%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5834 58.34%
Fish aquatic toxicity - 0.8662 86.62%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.32% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 85.66% 95.93%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.65% 91.11%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 84.37% 96.95%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.26% 99.17%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.29% 85.14%
CHEMBL3922 P50579 Methionine aminopeptidase 2 80.85% 97.28%

Cross-Links

Top
PubChem 111162
NPASS NPC302760